Natural Product: NPC536600

Natural Product IDNPC536600
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Octadeca-5,9,12,15-tetraenoic acid
IUPAC Name octadeca-5,9,12,15-tetraenoic acid
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey DNOBNGNBPVOMLW-UHFFFAOYSA-N
Standard InCHI InChI=1S/C18H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10,13-14H,2,5,8,11-12,15-17H2,1H3,(H,19,20)
SMILES CCC=CCC=CCC=CCCC=CCCCC(=O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   276.21 Volume:   324.282
?
Van der Waals volume.
Dense:   0.852 LogP:   6.16
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.267
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.443
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   12.0 Rigid Bonds:   5.0
TPSA:   37.3
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   1.0 Rings:   0.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.381 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.907 Fsp3:   0.5
MCE-18:   0.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.03 Fluc inhibitor:   0.331
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.006
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.004
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.998 Promiscuous compounds:   0.527

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.034 MDCK Permeability:   -4.832
Pgp-inhibitor:   0.003 Pgp-substrate:   0.003
PAMPA:   0.576
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.036
20% Bioavailability (F20%):   0.023 30% Bioavailability (F30%):   0.294
50% Bioavailability (F50%):   0.131

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.329 MRP1:   0.961
Plasma Protein Binding (PPB):   97.625% Volume Distribution (VD):   -0.633
Fu: 2.466%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.222
OATP1B3 inhibitor:   0.574 BCRP inhibitor:   0.01
BSEP inhibitor:   0.398

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.002
CYP2C19-inhibitor:   0.988 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.99 CYP2D6-substrate:   0.002
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   1.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.003
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.326 Half-life (T1/2):  0.271

ADMET: Toxicity

hERG Blockers:  0.057 hERG Blockers (10um):  0.161
Human Hepatotoxicity (H-HT):  0.145 Drug-induced Liver Injury (DILI):  0.004
AMES Toxicity:  0.423 Rat Oral Acute Toxicity:  0.105
Maximum Recommended Daily Dose:  0.13 Skin Sensitization:  0.998
Carcinogencity:  0.199 Eye Corrosion:  0.982
Eye Irritation:  0.995 Respiratory Toxicity:  0.825
Drug-induced Neurotoxicity:  0.048 Ototoxicity:  0.381
Hematotoxicity:  0.044 Drug-induced Nephrotoxicity:  0.227
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.025
A549 Cytotoxicity:  0.017 Hek293 Cytotoxicity:  0.021
BCF:   1.204
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.809
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.097
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.084
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4011 Chlamydomonas reinhardtii Species Chlamydomonadaceae Eukaryota n.a. n.a. n.a. PMID[20581114]
NPO4011 Chlamydomonas reinhardtii Species Chlamydomonadaceae Eukaryota n.a. n.a. n.a. PMID[25515814]
NPO4011 Chlamydomonas reinhardtii Species Chlamydomonadaceae Eukaryota n.a. n.a. n.a. Database[Article]
NPO9262 Chamaecyparis hodginsii Species Cupressaceae Eukaryota n.a. seed n.a. Database[Article]
NPO4011 Chlamydomonas reinhardtii Species Chlamydomonadaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO9262 Chamaecyparis hodginsii Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO4011 Chlamydomonas reinhardtii Species Chlamydomonadaceae Eukaryota n.a. n.a. n.a. Database[MetaboLights]
NPO4011 Chlamydomonas reinhardtii Species Chlamydomonadaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9262 Chamaecyparis hodginsii Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC536600 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9615 High Similarity NPC117572
0.7667 Intermediate Similarity NPC149821
0.7419 Intermediate Similarity NPC91495
0.7419 Intermediate Similarity NPC70387
0.7188 Intermediate Similarity NPC52955
0.7188 Intermediate Similarity NPC88966
0.7188 Intermediate Similarity NPC25417
0.7188 Intermediate Similarity NPC1813
0.7188 Intermediate Similarity NPC59051
0.6389 Remote Similarity NPC323436
0.6389 Remote Similarity NPC327388
0.6364 Remote Similarity NPC321062
0.6364 Remote Similarity NPC48162
0.6364 Remote Similarity NPC5413
0.6333 Remote Similarity NPC270796
0.6176 Remote Similarity NPC154245
0.6176 Remote Similarity NPC85813
0.6176 Remote Similarity NPC223697
0.6176 Remote Similarity NPC6095
0.6061 Remote Similarity NPC207292
0.575 Remote Similarity NPC323597
0.575 Remote Similarity NPC211752
0.575 Remote Similarity NPC323498
0.561 Remote Similarity NPC320305
0.561 Remote Similarity NPC321838
0.5526 Remote Similarity NPC284212
0.55 Remote Similarity NPC477779
0.5476 Remote Similarity NPC325977
0.5476 Remote Similarity NPC327112
0.5455 Remote Similarity NPC281245
0.5349 Remote Similarity NPC328311
0.5294 Remote Similarity NPC424
0.5294 Remote Similarity NPC36061
0.5294 Remote Similarity NPC69510
0.5294 Remote Similarity NPC77272
0.5294 Remote Similarity NPC290563
0.5294 Remote Similarity NPC139029
0.5294 Remote Similarity NPC281972
0.5294 Remote Similarity NPC92114
0.5294 Remote Similarity NPC261831
0.5294 Remote Similarity NPC87564
0.5227 Remote Similarity NPC322461
0.5185 Remote Similarity NPC174368
0.5111 Remote Similarity NPC605544
0.5111 Remote Similarity NPC607260

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC536600 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9615 High Similarity NPD4222 Phase 3
0.7188 Intermediate Similarity NPD3172 Approved
0.641 Remote Similarity NPD39 Phase 4
0.6364 Remote Similarity NPD3173 Phase 4
0.6333 Remote Similarity NPD5326 Phase 3
0.6176 Remote Similarity NPD4266 Phase 2
0.5476 Remote Similarity NPD4246 Phase 2
0.5294 Remote Similarity NPD3195 Phase 2
0.5294 Remote Similarity NPD3196 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data